Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

166.04
Delayed Data
As of 4:00pm ET
 -1.41 / -0.84%
Today’s Change
133.64
Today|||52-Week Range
184.21
+13.56%
Year-to-Date
Stock Research Reports for Amgen, Berkshire & Walgreens
3:46pm / Zacks.com - Paid Partner Content
Biotech Bull Making a Comeback
Mar 21 / Zacks.com - Paid Partner Content
Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valean...
Mar 22 / Zacks.com - Paid Partner Content
Barrick Gold (ABX) - Billionaires Are Cornering the Gold Market
Mar 20 / Investing Channel - Paid Partner Content
Biotech Stock Roundup: Amgen Down on Repatha Data, Nektar Surges on Pain Results
Mar 22 / Zacks.com - Paid Partner Content
Using Amazon (AMZN) Options to Beat the Stock
Mar 20 / Investing Channel - Paid Partner Content
4 Health Care Charts Signaling Buys: Pfizer, Amgen Included
Mar 21 / TheStreet.com - Paid Partner Content
Amgen (AMGN): Repatha Outcomes Data Disappoint, Shares Drop
Mar 20 / Zacks.com - Paid Partner Content
3 Biotech Stocks That Are Broker Favorites
Mar 21 / Zacks.com - Paid Partner Content
Why Biotech Stock Gilead (GILD) Could Be a Value Trap
Mar 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close167.45
Today’s open167.48
Day’s range165.57 - 168.02
Volume3,862,745
Average volume (3 months)3,924,313
Market cap$123.3B
Dividend yield2.77%
Data as of 4:00pm ET, 03/23/2017

Growth & Valuation

Earnings growth (last year)+13.02%
Earnings growth (this year)+6.02%
Earnings growth (next 5 years)+6.55%
Revenue growth (last year)+6.31%
P/E ratio16.2
Price/Sales4.86
Price/Book4.14

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.34-0.50%
BIIBBiogen-2.46-0.89%
ILMNIllumina Inc-0.10-0.06%
BIVVBioverativ Inc-0.83-1.62%
Data as of 4:15pm ET, 03/23/2017

Financials

Next reporting dateApril 25, 2017
EPS forecast (this quarter)$2.98
Annual revenue (last year)$22.7B
Annual profit (last year)$7.7B
Net profit margin34.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts


Search for Jobs